Replies to post #16727 on BioCurex, Inc.(fka BOCX)

[Kag]

Opportunity Knocking,
You just posted: "Look with your own two eyes. Open them. What do you see?

My comment: I see data that was likely done in house by BioCurex. I don't see any indication of independent validation of the data. I see data with completely different RECAF cutoff levels for each different type of cancer which no RECAF test can identify. Yesterday, I saw an abstract that indicated that the ELISA RECAF test has 5% less sensitivity than the chemiluminescence RECAF test. kag